Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions

In 2017, facing lack of progress and failures encountered in targeted drug development for Autism Spectrum Disorder (ASD) and related neurodevelopmental disorders, the ISCTM with the ECNP created the ASD Working Group charged to identify barriers to progress and recom-mending research strategies for...

Descripción completa

Detalles Bibliográficos
Autores principales: McCracken, James T., Anagnostou, Evdokia, Arango, Celso, Dawson, Geraldine, Farchione, Tiffany, Mantua, Valentina, McPartland, James, Murphy, Declan, Pandina, Gahan, Veenstra-VanderWeele, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062405/
https://www.ncbi.nlm.nih.gov/pubmed/34158222
http://dx.doi.org/10.1016/j.euroneuro.2021.05.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062405/
https://www.ncbi.nlm.nih.gov/pubmed/34158222
http://dx.doi.org/10.1016/j.euroneuro.2021.05.010

Ejemplares similares